Ausgabe 1/2021
Inhalt (29 Artikel)
MAPK signaling pathway-targeted marine compounds in cancer therapy
Jiaen Wei, Ruining Liu, Xiyun Hu, Tingen Liang, Zhiran Zhou, Zunnan Huang
Response rate and safety in patients with hepatocellular carcinoma treated with transarterial chemoembolization using 40-µm doxorubicin-eluting microspheres
Katharina Carolin Albrecht, René Aschenbach, Ioannis Diamantis, Niklas Eckardt, Ulf Teichgräber
High Wilms’ tumor 1 associating protein expression predicts poor prognosis in acute myeloid leukemia and regulates m6A methylation of MYC mRNA
Duolan Naren, Tianyou Yan, Yuping Gong, Jingcao Huang, Dan Zhang, Lina Sang, Xue Zheng, Yarong Li
Panel of potential lncRNA biomarkers can distinguish various types of liver malignant and benign tumors
Olga Y. Burenina, Natalia L. Lazarevich, Inna F. Kustova, Daria A. Shavochkina, Ekaterina A. Moroz, Nikolay E. Kudashkin, Yuriy I. Patyutko, Alexey V. Metelin, Eduard F. Kim, Dmitry A. Skvortsov, Timofei S. Zatsepin, Maria P. Rubtsova, Olga A. Dontsova
Stratification of Stage III colon cancer may identify a patient group not requiring adjuvant chemotherapy
Yasir G. Malik, Lars Gustav Lyckander, Jonas C. Lindstrøm, Olof Vinge-Holmquist, Ariba E. Sheikh, Johannes K. Schultz, Dejan Ignjatovic
Antineoplastic effects of targeting CCR5 and its therapeutic potential for colorectal cancer liver metastasis
Asim Pervaiz, Michael Zepp, Rania Georges, Frank Bergmann, Saqib Mahmood, Syeda Faiza, Martin R. Berger, Hassan Adwan
Gemcitabine potentiates anti-tumor effect of resveratrol on pancreatic cancer via down-regulation of VEGF-B
Yinan Yang, Wencong Tian, Lei Yang, Qiong Zhang, Mengmeng Zhu, Yuansheng Liu, Jing Li, Liang Yang, Jie Liu, Yanna Shen, Zhi Qi
Elevated ZBTB7A expression in the tumor invasive front correlates with more tumor budding formation in gastric adenocarcinoma
Yujing Sun, Junyi He, Duan-Bo Shi, Hui Zhang, Xu Chen, Ai-Yan Xing, Peng Gao
Analysis of genomic pathogenesis according to the revised Bethesda guidelines and additional criteria
Jin Cheon Kim, Jong Hwan Kim, Ye Jin Ha, Chan Wook Kim, Ka Hee Tak, Yong Sik Yoon, Yi Hong Kwon, Seon Ae Roh, Dong-Hyung Cho, Seon-Kyu Kim, Seon-Young Kim, Yong Sung Kim
B-MYB—p53-related relevant regulator for the progression of clear cell renal cell carcinoma
M. Nientiedt, K. Müller, K. Nitschke, P. Erben, A. Steidler, S. Porubsky, Z. V. Popovic, F. Waldbillig, J. Mühlbauer, M. C. Kriegmair
Association between the use of aspirin and risk of lung cancer: results from pooled cohorts and Mendelian randomization analyses
Yu Jiang, Zixuan Su, Caichen Li, Runchen Wang, Yaokai Wen, Hengrui Liang, Jianxing He, Wenhua Liang
An immune-related gene signature for determining Ewing sarcoma prognosis based on machine learning
En-hui Ren, Ya-jun Deng, Wen-hua Yuan, Zuo-long Wu, Guang-zhi Zhang, Qi-qi Xie
MET canonical transcript expression is a predictive biomarker for chemo-sensitivity to MET-inhibitors in hepatocellular carcinoma cell lines
Wafaa M. Rashed, Mohamed A. Kandeil, Mohamed O. Mahmoud, Doha Maher, Sameera Ezzat, Mohamed H. Abdel-Rahman
Mendelian randomization study indicates lack of causal relationship between physical activity and lung cancer
Wei Xian, Jiayi Shen, Huaqiang Zhou, Jiaqing Liu, Yaxiong Zhang, Zhonghan Zhang, Ting Zhou, Shaodong Hong, Yunpeng Yang, Wenfeng Fang, Hongyun Zhao, Yan Huang, Li Zhang
BRAFV600E, hypothyroidism, and human relaxin in thyroid carcinogenesis
Brenda Y. Hernandez, Mobeen Rahman, Lenora W. M. Loo, Owen T. M. Chan, David Horio, Shane Morita, Gillian Bryant-Greenwood
Risk of lung cancer and renin–angiotensin blockade: a concise review
Tobias Rachow, Helmut Schiffl, Susanne M. Lang
Elotuzumab, pomalidomide, and dexamethasone is a very well tolerated regimen associated with durable remission even in very advanced myeloma: a retrospective study from two academic centers
Dorothea Hose, Martin Schreder, Jochen Hefner, Max Bittrich, Sophia Danhof, Susanne Strifler, Maria-Theresa Krauth, Renate Schoder, Bettina Gisslinger, Hermann Einsele, Heinz Gisslinger, Stefan Knop
A nanowire-based liquid biopsy method using cerebrospinal fluid cell-free DNA for targeted management of leptomeningeal carcinomatosis
Wonyoung Choi, Youngnam Cho, Seog-Yun Park, Kum Hui Hwang, Ji-Youn Han, Youngjoo Lee
Stem signatures associated antibodies yield early diagnosis and precise prognosis predication of patients with non-small cell lung cancer
Si-Si Chen, Kai Li, Jie Wu, Zi-Yang Peng, Zhi-Dong Wang, Ji-Chang Wang, Chong-Wen Xu, Cai-lin Zhu, Bao-Cheng Li, Hong Ren, Shou-Ching Tang, Xin Sun
Results of a randomized trial of treatment modalities in patients with low or early-intermediate risk prostate cancer (PREFERE trial)
Thomas Wiegel, Peter Albers, Detlef Bartkowiak, Roswitha Bussar-Maatz, Martin Härter, Glen Kristiansen, Peter Martus, Stefan Wellek, Heinz Schmidberger, Klaus Grozinger, Peter Renner, Fried Schneider, Martin Burmester, Michael Stöckle
Correction to: Results of a randomized trial of treatment modalities in patients with low or early-intermediate risk prostate cancer (PREFERE trial)
Thomas Wiegel, Peter Albers, Detlef Bartkowiak, Roswitha Bussar-Maatz, Martin Härter, Glen Kristiansen, Peter Martus, Stefan Wellek, Heinz Schmidberger, Klaus Grozinger, Peter Renner, Fried Schneider, Martin Burmester, Michael Stöckle
Efficacy of anti-PD-1 antibodies in NSCLC patients with an EGFR mutation and high PD-L1 expression
Ken Masuda, Hidehito Horinouchi, Midori Tanaka, Ryoko Higashiyama, Yuki Shinno, Jun Sato, Yuji Matsumoto, Yusuke Okuma, Tatsuya Yoshida, Yasushi Goto, Noboru Yamamoto, Yuichiro Ohe
Age-stratified clinical performance and survival of patients with IDH-wildtype glioblastoma homogeneously treated by radiotherapy with concomitant and maintenance temozolomide
Kerstin Berger, Bernd Turowski, Jörg Felsberg, Bastian Malzkorn, Guido Reifenberger, Hans-Jakob Steiger, Wilfried Budach, Jan Haussmann, Johannes Knipps, Marion Rapp, Daniel Hänggi, Michael Sabel, Hendrik-Jan Mijderwijk, Marcel A. Kamp
Clinical responses to PD-1 inhibition and their molecular characterization in six patients with mismatch repair-deficient metastatic cancer of the digestive system
Daniela Hirsch, Timo Gaiser, Kirsten Merx, Simone Weingaertner, Michael Forster, Alexander Hendricks, Matthias Woenckhaus, Thomas Schubert, Ralf-Dieter Hofheinz, Deniz Gencer
A prediction model to evaluate the pretest risk of malignancy in solitary pulmonary nodules: evidence from a large Chinese southwestern population
Zuohong Wu, Tingting Huang, Shiqi Zhang, Deyun Cheng, Weimin Li, Bojiang Chen
Overall survival of super-elderly (85 years or older) advanced non-small cell lung cancer patients with active epidermal growth factor receptor mutations receiving first-line gefitinib therapy: a single-institute retrospective study
Kosuke Kashiwabara, Shinji Fujii, Shinsuke Tsumura, Kazuhiko Sakamoto
Peripheral blood T lymphocytosis in thymoma: an insight into immunobiology
Shruti Mishra, Somanath Padhi, Amit Kumar Adhya, Saroj Kumar DasMajumdar, Ashutosh Pattnaik, Gaurav Chhabra